Top Story

Bevacizumab improves pathological complete response in HER-2–negative early breast cancer

June 30, 2015

The addition of four cycles of bevacizumab to standard neoadjuvant chemotherapy significantly improved the pathological complete response rate among patients with HER-2–negative early-stage breast cancer, according to the results of a phase 3 study.

However, the impact of improved pathological complete response on OS and DFS remains undetermined, according to the researchers.

In the Journals

Gardasil 9 HPV vaccine also safe, effective in younger boys, girls

June 30, 2015
Recent study data showed that Gardasil 9 HPV vaccine also is safe and effective in boys and girls aged 9 to 15 years, advancing previous research that found similar…
Medicare fraud takedown: A closer look Health Care Legislative and Regulatory Update

Medicare fraud takedown: A closer look

June 30, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals

Aggressive squamous cell carcinoma predicted by immunosuppression, cigarette use

June 30, 2015
Researchers from the University of California, San Diego found that incidence of squamous cell carcinoma with an aggressive subclinical extension can be predicted by…
In the JournalsPerspective

Genomic data may better classify lower-grade glioma than histology

June 30, 2015
IDH, 1p/19q and TP53 status more accurately represented three molecular classes of lower-grade gliomas than histologic class, according to study results.Lower-grade…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
morganatic-roan